½ÃÀ庸°í¼­
»óǰÄÚµå
1363969

¼¼°èÀÇ ÀçÅÃÀÇ·á ½ÃÀå(2023-2030³â)

Global Home Healthcare Market 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Orion Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 105 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀçÅÃÀÇ·á ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È ¿¬Æò±Õ 11.2%ÀÇ ³ôÀº ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀçÅÃÀÇ·á ½ÃÀå¿¡¼­ ¼÷·ÃµÈ °£È£»ç°¡ Áö¹èÀûÀÎ ¼­ºñ½º·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÀÌ Àü¹®Àû Ä¡·á´Â ÈÆ·Ã¹Þ°í ÀÚ°ÝÀ» °®Ãá °£È£»ç°¡ Á¦°øÇϸç, ȯÀÚ´Â Áý¿¡ ÀÖÀ¸¸é¼­ Á¾ÇÕÀûÀÎ ÀÇ·á Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È ¿ø°Ý ÀÇ·á°¡ È®´ëµÈ ÀÌÈÄ, ÀÇ·á ÀÌÇØ°ü°èÀÚµéÀº À̵¿ÇÏÁö ¾Ê°íµµ ȯÀÚ¸¦ Áö¿øÇϱâ À§ÇØ °¡»ó ÀǷḦ Ȱ¿ëÇÏ´Â ¹æ¹ýÀ» ¸ð»öÇß½À´Ï´Ù. ¸¦ Ȱ¿ëÇÏ´Â ¹æ¹ýÀ» ¸ð»öÇß½À´Ï´Ù. °¡»ó ¹æ¹®, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ÀçÅà Áø·á ¼Ö·ç¼ÇÀº ¿ø°Ý Áø·á Á¦°øÀÇ ³ôÀº Àα⸦ µÞ¹ÞħÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù ÀÎŬ·çµå Çコ(Include Health)¿Í µð½ºÆÐÄ¡ Çコ(DispatchHealth)ÀÇ Á¦ÈÞ¸¦ ÅëÇØ ºÎ»ó, Áúº´, ÁúȯÀ» ¾Î°í Àִ ȯÀÚ°¡ Áý¿¡ ¸Ó¹«¸¦ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â °¡»ó ȨÄÉ¾î ¸ðµ¨ÀÌ Åº»ýÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÈï ½ÃÀåÀÇ ¹ßÀüÀº Àü ¼¼°è ÀçÅÃÀÇ·á ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®º° Àü¸Á

Ä¡·á¿ë Á¦Ç°ÀÌ ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÇÏÀ§ ºÎ¹®

µ¶Æ¯ÇÑ µ¶ÀÚÀûÀÎ °æ±¸ Àü´Þ Ç÷§ÆûÀ» ÀÌ¿ëÇÑ Ç¥Àû ¸é¿ª ±â¹Ý »ý¹°ÇÐÀû Á¦Á¦ÀÇ °³¹ßÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, Á¦Ç° Áß Ä¡·á¿ë Á¦Ç°ÀÇ ÇÏÀ§ ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº° Àü¸Á

¼¼°è Ȩ ÇコÄÉ¾î ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ À¯·´ Áö¿ª), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾Æ Áö¿ª), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ³²¹Ì) µî Áö¿ªº°·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì´Â ÀçÅÃÀÇ·á Á¦Ç° ¹× ¼­ºñ½ºÀÇ Áõ°¡·Î ÀÎÇØ ¼¼°è ½ÃÀå¿¡¼­ µÎµå·¯Áø Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, American Home Health Corp, Covenant Care Home Health¿Í °°Àº ÁÖ¿ä ±â¾÷ÀÇ Á¸Àç´Â ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç, ¼¼°è ÀçÅÃÀÇ·á ½ÃÀå¿¡¼­ ³ôÀº CAGR·Î ¼ºÀåÇÒ Àü¸Á

¸ðµç Áö¿ª Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀº ÀÌ Áö¿ªÀÇ ¹æ´ëÇÑ ³ëÀÎ Àα¸, Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó, »ó´ëÀûÀ¸·Î ³ôÀº °¡Ã³ºÐ ¼Òµæ°ú ÇÔ²² ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅÃÀǷḦ Àå·ÁÇÏ¿© ÀÇ·áºñ ÁöÃâ ¼öÁØÀ» ¾ïÁ¦ÇÏ·Á´Â Á¤ºÎÀÇ ³ë·ÂÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ Áß¿äÇÑ ¿µÇâ·Â È®´ë ¿äÀÎÀ¸·Î ¿¹»óµË´Ï´Ù. ű¹, È£ÁÖ, Çѱ¹, ´ºÁú·£µå´Â ÀÌ Áö¿ªÀÇ ½ÅÈï±¹ Áß ÀϺÎÀÔ´Ï´Ù. ȯÀÚ ¸ð´ÏÅ͸µ ÀåºñÀÇ ±â¼ú ¹ßÀü, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ºñ¸¸ ¹× ´ç´¢º´°ú °°Àº »ýȰ½À°üº´ÀÇ È®»êÀº ÀÌ Áö¿ª ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹ÌºñÇÑ ÀÇ·á ÀÎÇÁ¶ó, °í°¡ÀÇ º´¿ø ½Ã¼³, Àå±â Ä¡·á°¡ ÇÊ¿äÇÑ ¸¸¼º Áúȯ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ÀçÅÃÀÇ·á Á¦Ç° ¹× ¼­ºñ½º äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¢ ±â¾÷µéÀº ÇâÈÄ ÀçÅÃÀÇ·á ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀÌ ±â´ëµÇ´Â °³¹ßµµ»ó±¹¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå º¸°í¼­ °³¿ä

  • ¾÷°è ÇöȲ ºÐ¼®°ú ¼ºÀå °¡´É¼º Àü¸Á
  • Á¶»ç ¹æ¹ý°ú Åø
  • ½ÃÀå ³»¿ª
    • ºÎ¹®º°
    • Áö¿ªº°

Á¦2Àå ½ÃÀå °³¿ä¿Í ÀλçÀÌÆ®

  • Á¶»ç ¹üÀ§
  • ¾Ö³Î¸®½ºÆ®ÀÇ ÀλçÀÌÆ®¿Í ÇöÀç ½ÃÀå µ¿Çâ
    • ÁÖ¿ä Á¶»ç °á°ú
    • Ãßõ»çÇ×
    • °á·Ð

Á¦3Àå °æÀï »óȲ

  • ÁÖ¿ä ±â¾÷ ºÐ¼®
  • Abbott Laboratories
    • °³¿ä
    • À繫 ºÐ¼®
    • SWOT ºÐ¼®
    • ÃÖ±ÙÀÇ µ¿Çâ
  • F. Hoffmann-La Roche AG
    • °³¿ä
    • À繫 ºÐ¼®
    • SWOT ºÐ¼®
    • ÃÖ±ÙÀÇ µ¿Çâ
  • Johnson & Johnson Services, Inc.
    • °³¿ä
    • À繫 ºÐ¼®
    • SWOT ºÐ¼®
    • ÃÖ±ÙÀÇ µ¿Çâ
  • ÁÖ¿ä Àü·« ºÐ¼®

Á¦4Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÀçÅÃÀÇ·á ½ÃÀå : ÄÄÆ÷³ÍÆ®º°
    • Àåºñ
    • ¼­ºñ½º
  • ¼¼°èÀÇ ÀçÅÃÀÇ·á ½ÃÀå : Á¦Ç°º°
    • Ä¡·á¿ë Á¦Ç°
    • °Ë»ç
    • ½ºÅ©¸®´×¡¤¸ð´ÏÅ͸µ Á¦Ç°
    • ¸ðºô¸®Æ¼ Äɾî Á¦Ç°
  • ¼¼°èÀÇ ÀçÅÃÀÇ·á ½ÃÀå : ¼­ºñ½ºº°
    • ¼÷·Ã °£È£
    • ÀçȰ¿ä¹ý
    • È£½ºÇǽº¡¤¿ÏÈ­ Äɾî
    • ¹Ì¼÷·Ã Äɾî
    • È£Èí¿ä¹ý
    • ÁÖÀÔ¿ä¹ý
    • ÀӽŠÄɾî
  • ¼¼°èÀÇ ÀçÅÃÀÇ·á ½ÃÀå : ÀûÀÀÁõº°
    • ¾Ï
    • È£Èí±âÁúȯ
    • ¿îµ¿Àå¾Ö
    • ½ÉÇ÷°üÁúȯ¡¤°íÇ÷¾Ð
    • ´ç´¢º´
    • ±âŸ(â»ó°ü¸®, ÀÓ½Å)

Á¦5Àå Áö¿ª ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°è ±âŸ Áö¿ª

Á¦6Àå ±â¾÷ °³¿ä

  • 3M Healthcare
  • Acelity(3 M)
  • Amedisys, Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Bayer HealthCare Inc.
  • Becton, Dickinson and Company
  • Cardinal Health Inc.
  • Drive DeVilbiss Healthcare
  • Fresenius Kabi AG.
  • GE Healthcare
  • GF Health Products, Inc.
  • Intersurgical Ltd.
  • Koninklijke Philips N.V.
  • Linde Healthcare Plc
  • Medline Industries, Inc
  • Medtronic PLC
  • Moog Inc.
  • NxStage Medical, Inc.(Fresenius Medical Care)
  • Omron Healthcare, Inc.
  • Sunrise Medical
  • Teleflex, Inc.
ksm 23.10.26

Title: Global Home Healthcare Market Size, Share & Trends Analysis Report by Component (Equipment and Services), by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, and Mobility Care Products), and by Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), and by Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Diabetes and Others),Forecast Period (2023-2030).

The global home healthcare market is anticipated to grow at a significant CAGR of 11.2% during the forecast period (2023-2030). Skilled nursing is emerging as the dominant service in the home healthcare market. This specialized form of care is provided by trained and licensed nurses who offer comprehensive medical support to patients in the comfort of their homes. Following the expansion of telehealth during the COVID-19 pandemic, healthcare stakeholders have examined ways to use virtual care to assist patients without the need for travel. Virtual visits, remote patient monitoring, and at-home care solutions have supported the growing popularity of remote care delivery. For instance, in May 2023, a partnership between Included Health and DispatchHealth led to the creation of a virtual-to-in-home care model to support patients with injuries, illnesses, and diseases while allowing them to remain in their homes. Such developments are contributing to the growth of the global home healthcare market.

Segmental Outlook

The global home healthcare market is segmented on the components, products, services, and indications. Based on the component, the market is sub-segmented into equipment and services. Based on theproduct, the market is sub-segmented into therapeutic products, testing, screening, and monitoring products, and mobility care products. On the basis of service, the market is sub-segmented into skilled nursing, rehabilitation therapy, hospice & palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care. Furthermore, on the basis of indication, the market is sub-segmented intoskilled nursing, rehabilitation therapy, hospice and palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care.

The Therapeutic Products Sub-Segment is Anticipated to Hold a Considerable Share of the Market

Among the products, the therapeutic products sub-segment is anticipated to hold a considerable share of the market, owing to the rise in developing targeted immunological-based biologics using a unique and proprietary oral delivery platform.

Regional Outlook

The global home healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increase in home healthcare products and services. The presence of key market players including American Home Health Corp., Covenant Care Home Health, and others is further contributing to the regional market growth.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Home Healthcare Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the huge geriatric population in this region, coupled with sophisticated healthcare infrastructure and relatively high disposable incomes, are some key drivers of this market. Moreover, an increasing number of government initiatives that aim to curb healthcare expenditure levels, by promoting home healthcare is expected to serve as a vital impact-rendering driver. Thailand, Australia, South Korea, and New Zealand are some of the emerging countries in the region. Technological advancements in patient monitoring devices and an increasing geriatric population coupled with the growing prevalence of lifestyle diseases, such as obesity & diabetes, are anticipated to drive the growth of the regional market.

Some factors such as underdeveloped healthcare infrastructure, expensive in-hospital healthcare facilities, and chronic diseases requiring long-term care result in increasing adoption of home healthcare products and services- companies are focusing on developing countries that will boost home healthcare services market in the upcoming future.

Market Players Outlook

The major companies serving the home healthcare market include Abbott Laboratories, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc. Baxter International Inc., 3M Healthcare, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, GE Healthcare and AMC Health announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment. GE Healthcare and AMC Health to partner in remote patient monitoring to provide patients with chronic and post-acute care in the home.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global home healthcare market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. F. Hoffmann-La Roche AG
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Johnson & Johnson Services, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Home Healthcare Market by Component
    • 4.1.1. Equipment
    • 4.1.2. Services
  • 4.2. Global Home Healthcare Market by Product
    • 4.2.1. Therapeutic Products
    • 4.2.2. Testing
    • 4.2.3. Screening and Monitoring Products
    • 4.2.4. Mobility Care Products
  • 4.3. Global Home Healthcare Market by Service
    • 4.3.1. Skilled Nursing
    • 4.3.2. Rehabilitation Therapy
    • 4.3.3. Hospice & Palliative Care
    • 4.3.4. Unskilled Care
    • 4.3.5. Respiratory Therapy
    • 4.3.6. Infusion Therapy
    • 4.3.7. Pregnancy Care
  • 4.4. Global Home HealthcareMarket by Indication
    • 4.4.1. Cancer
    • 4.4.2. Respiratory Diseases
    • 4.4.3. Movement Disorders
    • 4.4.4. Cardiovascular Diseases & Hypertension
    • 4.4.5. Diabetes
    • 4.4.6. Others (wound care, pregnancy)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3M Healthcare
  • 6.2. Acelity (3M)
  • 6.3. Amedisys, Inc.
  • 6.4. Arkray, Inc.
  • 6.5. B. Braun Melsungen AG
  • 6.6. Bayer HealthCare Inc.
  • 6.7. Becton, Dickinson and Company
  • 6.8. Cardinal Health Inc.
  • 6.9. Drive DeVilbiss Healthcare
  • 6.10. Fresenius Kabi AG.
  • 6.11. GE Healthcare
  • 6.12. GF Health Products, Inc.
  • 6.13. Intersurgical Ltd.
  • 6.14. Koninklijke Philips N.V.
  • 6.15. Linde Healthcare Plc
  • 6.16. Medline Industries, Inc
  • 6.17. Medtronic PLC
  • 6.18. Moog Inc.
  • 6.19. NxStage Medical, Inc. (Fresenius Medical Care)
  • 6.20. Omron Healthcare, Inc.
  • 6.21. Sunrise Medical
  • 6.22. Teleflex, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦